CoronaWatch Meeting Process
Be the first to know about BARDA news and new awards. Sign-up for our email announcements:
Currently, our attention is limited to COVID-19 response; as such, we are only reviewing meeting requests related to COVID-19.
Coronavirus Resources:
COVID-19 CoronaWatch requests from every state in the USA
550+ COVID-19 CoronaWatch Virtual Market Research Meetings with innovative companies
The U.S. government is providing a portal for the 2019 novel coronavirus (COVID-19) medical countermeasures task force as a single point of entry for the submission of market research packages and meeting requests from interested stakeholders.
The U.S. government, in response to the COVID-19 outbreak, seeks information from stakeholders on available medical countermeasures in development. We are particularly interested in products and technologies that have progressed into or beyond clinical trials, have established large-scale cGMP manufacturing capability, or utilize an approved platform. Information regarding diagnostics, therapeutics, vaccines, and other products or technologies relevant to addressing this outbreak are sought.
We ask for a brief description of your product or technology, accompanied by a slide deck, manuscript, publications, or other non-confidential information of your choosing. Please note that while we will use any information you present as market research, submission is no guarantee of a meeting or funding and your submission will be shared across U.S. Government agencies involved in COVID-19 medical countermeasure research and development. Only U.S. government officials are invited to join a CoronaWatch meeting, and are bound by law to maintain confidentiality of what is presented and discussed.
CoronaWatch Meeting Process
Submit
Submit basic product information or View/update existing submissions.
Evaluate
We will evaluate your request and route it to the most appropriate resource within the federal government.
Notification
We will schedule a meeting.
OR
A meeting is not scheduled, but your technology is retained for future reference.
Before You Submit:
Submit
Submit basic product information or View/update existing submissions.
Evaluate
We will evaluate your request and route it to the most appropriate resource within the federal government.
Notification
We will schedule a meeting.
OR
A meeting is not scheduled, but your technology is retained for future reference.
Before You Submit:
To enable a rapid-response to the COVID-19 outbreak, BARDA has repurposed our existing TechWatch program to focus on COVID-19 medical countermeasures. These CoronaWatch submissions and meetings aim to give innovators and innovative companies a government-wide platform to discuss their ideas with U.S. government experts, and seek partnership opportunities with a wide range of potential federal partners.
Note: TechWatch submissions are not considered for potential funding
Note: Entities with a White Paper or proposal currently under review for any ASPR solicitation are not eligible to schedule a TechWatch meeting related to that submission. If you have concerns regaring your eligibility, please raise them with our TechWatch team as soon as possible.
